https://www.zacks.com/stock/news/2223762/forrester-research-forr-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2223762
Feb 08, 2024 - The headline numbers for Forrester Research (FORR) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:7784040783940472593
0
https://www.zacks.com/stock/news/2223734/pinterest-pins-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2223734
Feb 08, 2024 - While the top- and bottom-line numbers for Pinterest (PINS) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-5140953883782584245
0
https://www.zacks.com/stock/news/2223735/compared-to-estimates-motorola-msi-q4-earnings-a-look-at-key-metrics?cid=CS-ZC-FT-fundamental_analysis|nfm-2223735
Feb 08, 2024 - Although the revenue and EPS for Motorola (MSI) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-701979740177352294
0
https://www.zacks.com/stock/news/2223736/mohawk-industries-mhk-q4-earnings-taking-a-look-at-key-metrics-versus-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2223736
Feb 08, 2024 - Although the revenue and EPS for Mohawk Industries (MHK) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-7576332559124972074
0
https://www.zacks.com/stock/news/2223739/bill-holdings-bill-q2-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2223739
Feb 08, 2024 - While the top- and bottom-line numbers for BILL Holdings (BILL) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-4780356908050911022
0
https://www.zacks.com/stock/news/2223737/here-s-what-key-metrics-tell-us-about-healthpeak-peak-q4-earnings?cid=CS-ZC-FT-fundamental_analysis|nfm-2223737
Feb 08, 2024 - While the top- and bottom-line numbers for Healthpeak (PEAK) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:-9059786460256732418
0
https://www.zacks.com/stock/news/2223738/expedia-expe-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2223738
Feb 08, 2024 - While the top- and bottom-line numbers for Expedia (EXPE) give a sense of how the business performed in the quarter ended December 2023, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
zc:372939183296132692
0
https://www.zacks.com/stock/news/2223683/dexcom-dxcm-reports-q4-earnings-what-key-metrics-have-to-say?cid=CS-ZC-FT-fundamental_analysis|nfm-2223683
Feb 08, 2024 - The headline numbers for DexCom (DXCM) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
zc:7734774980997884790
0
https://www.rttnews.com/story.aspx?Id=3423374
Feb 08, 2024 - Following the strong upward move seen over the course of the previous session, stocks turned in a relatively lackluster performance during trading on Thursday before closing modestly higher. The S&P 500 reached an intraday peak slightly above 5,000 in late-day trading but pulled back to close just below what could prove to be a key psychological level for the broad market index.
0
rttnews:1072046400355335094
0
https://www.zacks.com/stock/news/2223659/astrazeneca-azn-q4-earnings-how-key-metrics-compare-to-wall-street-estimates?cid=CS-ZC-FT-fundamental_analysis|nfm-2223659
Feb 08, 2024 - Although the revenue and EPS for Astrazeneca (AZN) give a sense of how its business performed in the quarter ended December 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
zc:-4085657557894865847
0